Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
810,815
-
Share change
-
+551,266
-
Total reported value
-
$36,440,000
-
Price per share
-
$44.94
-
Number of holders
-
30
-
Value change
-
+$25,376,026
-
Number of buys
-
25
-
Number of sells
-
8
Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q2 2021
As of 30 Jun 2021,
Greenwich LifeSciences, Inc. - COM (GLSI) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
810,815 shares.
The largest 10 holders included
Invesco Ltd., BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, MORGAN STANLEY, SkyOak Wealth, LLC, and Bank of New York Mellon Corp.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.